Judit Pich
Clinical trials sponsored by Judit Pich, explained in plain language.
-
New immune therapy aims to tame multiple sclerosis Flare-Ups
Disease control OngoingThis study tests a new treatment that uses a patient's own immune cells (dendritic cells) to help control relapsing-remitting multiple sclerosis (MS). About 45 adults with MS will receive this cell therapy along with their usual MS medications. The goal is to see if the combinati…
Phase: PHASE2 • Sponsor: Judit Pich • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New HIV cocktail aims for Long-Term remission without daily meds
Disease control TerminatedThis study aimed to see if a combination of a therapeutic vaccine, a broadly neutralizing antibody (10-1074), and a drug called romidepsin could help people with HIV control the virus without needing daily antiretroviral therapy. The trial planned to enroll 56 adults with well-co…
Phase: PHASE1, PHASE2 • Sponsor: Judit Pich • Aim: Disease control
Last updated May 13, 2026 15:59 UTC